Issue #149
- CMV: Laboratory Study of Etoposide
- Antivirals, Vaccines, Passive Immunotherapy: Talk by Marcus Conant, M. D.
- San Francisco: Health Care Workers' Respiratory Hazards Conference, May 1 & 2
- San Francisco Area Clinical Trials Directory
- FDA Antiviral Advisory Committee Meeting to Consider ddC, ddI, Markers
- Rifabutin Available to Prevent MAC
- CMV: Long-Awaited Trial of HPMPC
source: AIDS Treatment News
